Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stereotypes, Prejudice, and Discrimination02:55

Stereotypes, Prejudice, and Discrimination

94.1K
Humans are very diverse and although we share many similarities, we also have many differences. The social groups we belong to help form our identities (Tajfel, 1974). These differences may be difficult for some people to reconcile, which may lead to prejudice toward people who are different. Prejudice is a negative attitude and feeling toward an individual based solely on one’s membership in a particular social group (Allport, 1954; Brown, 2010). Prejudice is common against people who...
94.1K
Aging01:26

Aging

445
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
445
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

102
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
102
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

111
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
111
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

99
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
99
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

78
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
78

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Needles, Haystacks and Next-Generation Genetic Sequencing.

Health matrix (Cleveland, Ohio : 1991)·2026
Same author

Patient Registries and Their Governance: A Pilot Study and Recommendations<sup></sup>.

Indiana health law review·2026
Same author

The Myth of the Designer Baby : Parents beware of any genomics firm saying it can help them with "genetic optimization" of their embryos.

Scientific American·2025
Same author

The Black Prisoners of Stateville: Race, Research, and Reckoning at the Dawn of Precision Medicine.

JAMA·2025
Same author

How to Diagnose Abhorrent Science.

The Hastings Center report·2024
Same author

Health Law and Bigotry Distractions.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2024
Same journal

Harm Reduction as an Alternative to Mandated Drug Treatment.

The Hastings Center report·2026
Same journal

Rethinking Mandated Drug Treatment: Why Expanding Freedom Requires Structural Drug Policy Reform.

The Hastings Center report·2026
Same journal

Banning Gender-Affirming Treatment for Minors: The Supreme Court Speaks.

The Hastings Center report·2026
Same journal

Making the Move to a Learning System of Research Ethics.

The Hastings Center report·2026
Same journal

Musical Performance and Biomedical Human Enhancement: Ethnographic Perspectives on Bioethical Questions.

The Hastings Center report·2026
Same journal

Transformed but Not Cured: The Ethics of Describing Gene-Editing Therapy for Sickle Cell Disease.

The Hastings Center report·2026
See all related articles

Related Experiment Video

Updated: Nov 25, 2025

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.5K

When Is Age Choosing Ageist Discrimination?

Teneille R Brown, Leslie P Francis, James Tabery

    The Hastings Center Report
    |December 15, 2020
    PubMed
    Summary
    This summary is machine-generated.

    During the Covid-19 pandemic, age was used in crisis care plans, first as exclusion, then as a tiebreaker. This analysis questions the ethical and legal basis for prioritizing patients based on age.

    Keywords:
    Covid-19agecrisis standards of carediscriminationtriage

    More Related Videos

    An Experimental Paradigm for Measuring the Effects of Ageing on Sentence Processing
    04:30

    An Experimental Paradigm for Measuring the Effects of Ageing on Sentence Processing

    Published on: October 25, 2019

    5.9K
    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
    12:18

    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

    Published on: January 11, 2020

    7.8K

    Related Experiment Videos

    Last Updated: Nov 25, 2025

    Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
    06:58

    Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

    Published on: January 24, 2020

    7.5K
    An Experimental Paradigm for Measuring the Effects of Ageing on Sentence Processing
    04:30

    An Experimental Paradigm for Measuring the Effects of Ageing on Sentence Processing

    Published on: October 25, 2019

    5.9K
    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
    12:18

    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

    Published on: January 11, 2020

    7.8K

    Area of Science:

    • Medical Ethics
    • Public Health Policy
    • Health Law

    Background:

    • The Covid-19 pandemic necessitated crisis standards of care (CSC) in many US states and hospitals.
    • Initial CSC plans often used age as a categorical exclusion criterion, raising discrimination concerns.
    • Subsequently, some plans incorporated age as a tiebreaker in resource allocation decisions.

    Purpose of the Study:

    • To critically analyze the rationales provided for using age as a tiebreaker in CSC plans.
    • To examine the ethical and legal justifications underpinning age-based tiebreakers in healthcare allocation.
    • To evaluate the implications of prioritizing younger patients over older patients in critical care settings.

    Main Methods:

    • Critical analysis of ethical and legal principles related to age discrimination in healthcare.
    • Examination of rationales for age-based tiebreakers: survival probability, life-years saved, and life-stage opportunities.
    • Review of existing literature and policy documents concerning CSC and age-based allocation.

    Main Results:

    • Identified three distinct rationales for using age as a tiebreaker: differential survival, maximizing life-years, and valuing life stages.
    • Highlighted the ethical and legal challenges associated with each rationale, particularly regarding fairness and equity.
    • Demonstrated that these rationales, while seemingly different, can lead to discriminatory outcomes.

    Conclusions:

    • The use of age as a tiebreaker in crisis standards of care is ethically and legally questionable.
    • Policies prioritizing patients based on age require rigorous scrutiny to prevent discrimination.
    • Further deliberation is needed to establish equitable and just criteria for resource allocation during public health emergencies.